Cahill Represents Financing Sources in Acquisition of Questcor by Mallinckrodt
Cahill represented Barclays, Deutsche Bank Securities, Citigroup, and Wells Fargo Securities as joint book-running managers and the co-managers in connection with the Rule 144A offering of $900,000,000 aggregate principal amount of 5.75% Senior Notes due 2022 by Mallinckrodt International Finance S.A. and Mallinckrodt CB LLC, a global pharmaceutical company. Proceeds were used in connection with Mallinckrodt’s acquisition of all of the capital stock and other equity interests of Questcor Pharmaceuticals, Inc., a California-based corporation.
Cahill also represented Barclays, Deutsche Bank Securities, Citigroup, and Wells Fargo Securities as the lead arrangers in connection with the $700,000,000 Incremental Term B-1 loan for Mallinckrodt. Proceeds were also used in connection with the acquisition.